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Vitamin D receptor (VDR) participates in multiple immune
functions. Here, we determined whether VDR gene-sequence variations are associated with intersubject differences in the risk of acquiring human immunodeficiency virus type 1 (HIV-1) infection. We assessed this in 460 males exposed to HIV-1 by injection drug use (335 infected and 125 uninfected) and 124 seronegative healthy subjects. Multilocus logistic regression analysis revealed haplotypes for rs11568820, rs4516035, rs10735810, rs1544410, and rs17878969 polymorphisms showing association with protection to HIV-1 infection (odds ratio, 0.4 [95% confidence interval, 0.22-0.72]; P ‫؍‬ .0025), which remained significant after correction for multiple testing. We infer that VDR haplotypes might influence the risk of HIV-1 acquisition.
After HIV-1 infects the host, HIV-1-specific cell-mediated immunity is generally unable to adequately control virus replication. In spite of this, some individuals resist HIV-1 infection and remain HIV-1 uninfected after multiple incidents of HIV-1 exposure. These exposed but uninfected individuals have been extensively studied in an attempt to identify the natural factors that confer resistance to infection. Evidence for the involvement of host genetic factors has been substantiated by the identification of polymorphisms in HLA and other immune-related genes that influence HIV-1 infection and progression to AIDS [1] .
Beyond its role in the regulation of mineral metabolism, vitamin D 3 (1[␣] ,25-dihydroxyvitamin-D 3 ) is also involved in immune-response modulation. Vitamin D 3 acts as an immunoregulatory hormone by (1) activating monocytes, (2) stimulating cell-mediated immunity, and (3) suppressing lymphocyte proliferation, antibody production, and cytokine synthesis [2] . In addition, epidemiological data involving vitamin D 3 with susceptibility to immune-related diseases emphasize the crucial role played by vitamin D 3 in the immune response. Following this, a potential role for vitamin D 3 in HIV-1 infection has been proposed [3] .
Vitamin D 3 acts through binding and activation of the nuclear vitamin D receptor (VDR). VDR is present on monocytes, dendritic cells, and activated T and B lymphocytes. VDR allelic variants have been described on the promoter, coding, and 3' untranslated (UTR) region with functional effects [4] and have been associated with immune-system disturbances [5] [6] [7] [8] [9] .
In the present work, we have examined the contribution of 5 polymorphisms in the VDR gene to the susceptibility to HIV-1 infection. We show differences in haplotype prevalence between 2 extreme populations, at-risk HIV-1-uninfected and HIV-1-infected subjects, from which we infer that VDR haplotypes might influence the risk of HIV-1 acquisition.
Methods. The study population consisted of 460 white males exposed to HIV-1 infection by injection drug use (IDU), both infected (335 subjects) and at-risk HIV-1 uninfected (125 subjects), enrolled in prospective cohort studies in Lleida and Seville (Spain) who had shared needles for Ͼ3 months. Concurrent hepatitis C virus (HCV) infection, the most chronic viral infection transmitted by sharing needles, was present in 100 (80%) at-risk HIV-1-uninfected subjects and in 320 (95.5%) HIV-1-infected subjects. These values are significantly higher than the reported HCV prevalence of 1%-2% for the general population in Spain. In addition, a group of 124 nonexposed white males recruited from anonymous blood donors testing HIV-1 and HCV negative was used as a control (healthy population). The main epidemiological and clinical characteristics of the populations studied are detailed in table 1. The ethics committees of the participant hospitals approved the study. All participants provided written informed consent.
HIV-1 antibodies were detected in serum by use of a commercial kit (MEIA; Abbott Laboratories). Positive results were confirmed by Western blot assay (INNO-LIA HIV; Innogenetics). Diagnosis of HCV infection was made on the basis of positive detection of anti-HCV and anti-HCV RNA antibodies (EIA; Ortho Diagnostic Systems). HCV RNA was detected by polymerase chain reaction (Cobas Amplicor HCV; HoffmanLaRoche).
All subjects were genotyped for 5 polymorphic markers located in the VDR genomic region: rs11568820 (Cdx), rs4516035 (A1012G), rs10735810 (FokI), rs1544410 (BsmI), and rs17878969 (PolyA) (figure 1) and the rs333 (⌬32) polymorphism in the CCR5 gene. VDR markers were selected according to 3 main criteria: (1) position-promoter 5' UTRs (rs11568820 and rs4516035), coding region (rs10735810), and 3' UTRs (rs1544410 and rs17878969); (2) known or putative functional effect-tran- Two blocks were identified, block 1 at the promoter 5' untranslated region (UTR) region (including markers rs4516035-rs11568820) and block 2 at the 3' UTR region (including markers rs17878969 -rs1544410). Block 2 was observed in all 3 cohorts, whereas block 1 was evident only in the healthy and HIV-1-infected subjects. Cds, coding sequence.
scriptional activity (rs11568820 and rs4516035), transactivation efficiency (rs10735810), and messenger RNA stability (rs1544410 and rs17878969) [4, 10] ; and (3) previous association with immune related diseases-psoriasis treatment (rs4516035), macrophage function (rs10735810 and rs1544410), and progression to AIDS (rs10735810 and rs1544410) [5, 7, 11] . DNA was extracted from fresh peripheral mononuclear blood cells (Lleida samples) and frozen whole blood (Seville samples). Genotyping was done following the protocols described in table 2. For each polymorphism, assay validation was performed using a minimum of 5 representative individuals whose genotypes had been previously determined by sequencing.
Hardy-Weinberg equilibrium and pairwise linkage disequilibrium (D') were calculated using Haploview software (version 3.32; http://www.broad.mit.edu/mpg/haploview/). Block structure was considered for marker pairs showing D' Ͼ 0.8, following the solid-spine block definition implemented in Haploview. D' values were plotted using Haploview facilities (figure 1). Haplotype frequencies were estimated and compared using WHAP software (http://www.broad.mit.edu/personal/shaun/ whap/). WHAP is a single-nucleotide polymorphism (SNP) haplotype analysis suite that performs a weighted logistic regression-based test of association in single-marker and multimarker designs under dominant and recessive models. The singlemarker analysis is a test with 1 df to derive the associated P value. For the multimarker analysis, each estimated haplotype included in the model and regression weights (␤ coefficients) were calculated to provide the relative contribution of each haplotype. The effect of each haplotype individually was estimated by use of the haplotype-specific option. Complementary analysis was performed by use of SPSS software (version 14.0). Single-marker association P values were corrected for multiple testing following the SNP spectral decomposition approach (http:// gump.qimr.edu.au/general/daleN/SNPSpD/). In multmarker association tests, we used a Bonferroni correction for multiple testing by dividing the significance level (.05) by the number of major haplotypes (i.e., Ͼ5%).
Results. Single-marker regression analysis revealed no significant association between any allele and HIV-1 infection. Genotype distribution was compared between all group combinations. We found an overrepresentation of rs4516035-[AAϩAG], rs1544410-[GGϩGA] and rs17878969-[LLϩLS] genotypes in at-risk uninfected subjects compared with both HIV-1-infected and healthy subjects. Differences reached statistical significance at the .05 level when at-risk uninfected subjects were compared with HIV-1-infected subjects (table 3) . Nevertheless, no association remained significant after correction for multiple testing based on the SNP spectral decomposition approach.
D' values were estimated by use of Haploview. Block structure (D' Ͼ 0.8) was observed among markers rs4516035-rs11568820 (block 1) in HIV-1-infected and healthy subjects (figure 1B and 1C) and among markers rs17878969 -rs1544410 (block 2) in all 3 populations (figure 1B-1D). In contrast, exon 2 polymorphism (rs10735810) did not show any significant linkage disequilibrium with either the promoter or the 3' UTR markers ( figure 1B-1D ). The observed linkage-disequilibrium pattern is in accordance with other data sets available for white populations [10] .
A haplotype-based association test was performed by multimarker regression analysis using WHAP software. Haplotype frequencies were estimated and compared among all groups considered (table 4) . No significant differences were observed between HIV-1-infected and healthy subjects. In contrast, 2 haplotypes- (table  4) . A similar trend was observed when HIV-1-infected subjects were compared with HIV-1-uninfected subjects, although significance was lost after Bonferroni correction (data not shown).
We also evaluated associations for block-specific haplotypes defined by markers located in blocks 1 and 2. A significant association with protection was observed for the block 1 haplotype GA (rs11568820-G:rs4516035-A) when both the haplotype effect and the haplotype-dominant model were considered (table  4) . In addition, the block 2 haplotype GL (rs1544410-G: rs17878969-L) showed a significant association with protection under the haplotype-dominant model (table 4) .
Interaction with CCR5 genotype, a well-known modifier factor of HIV-1 infection, was investigated. Regression analysis that included CCR5 genotype as covariate did not change the results obtained (data not shown). In addition, the confounding effects caused by the heterogeneous distribution of HCV prevalence between at-risk uninfected subjects and HIV-1-infected subjects were evaluated by limiting the association analysis to HCV- The haplotype-specific test was conducted by use of WHAP. Comparisons reaching statistical significance after correction for multiple testing are indicated in italics. Equivalent results were obtained when HIV-1-infected subjects and HIV-1-uninfected subjects (healthy and at-risk subjects considered together) were compared.
c
The dominant model was tested by comparing individuals carrying 1 or 2 copies of the selected haplotype with individuals carrying 0 copies of the haplotype. Rare haplotypes were considered to be those with a global frequency Ͻ5%: .2%) , and
e Rare haplotypes were considered to be those with global frequency Ͻ5%: GS (4.3%) and AL (2.9%).
positive individuals. The results obtained were similar with those described above. Associations between VDR variants and HCV infection were also explored. We did not find differences between HCV-positive individuals (HIV-1 infected and at-risk HIV-1 uninfected) and healthy controls (tables 5 and 6). Discussion. What role vitamin D 3 plays in infections is controversial. Several observations have suggested that activation of the vitamin D 3 signaling pathway mediates a positive response against Mycobacterium tuberculosis through induction of antimicrobial peptides [12] . Nevertheless, others have observed that the survival rate of Leishmania major-infected mice is reduced after vitamin D 3 treatment, supporting a negative role for the hormone [13] .
VDR plays a critical role mediating the response to vitamin D 3 . VDR polymorphisms have been associated with the clinical course of infections with 3 viruses: human T lymphotropic virus type 1 [8] , hepatitis B virus [6, 9] , and HIV-1 [5, 7] .
We have examined the contribution of 5 polymorphisms in the VDR gene on susceptibility to HIV-1 infection by testing for differences among 584 white males-460 exposed to HIV-1 infection by IDU (335 infected and 125 uninfected) and 124 healthy persons. Subjects in our at-risk uninfected cohort most likely have been exposed to HIV-1 after daily needle sharing over several months. Their "exposed" condition is also supported by the high prevalence of HCV infection and the borderline significant overrepresentation of the CCR5-⌬32 allele. Assuming that host genetic factors contribute to HIV-1 susceptibility, we can expect enrichment of protective factors in subjects who remain uninfected; on the flip side, the protective factors must be underrepresented in those who are HIV-1 infected. The HIV-1-infected subjects tested seropositive some years before the recruitment of the at-risk sample. Therefore, we cannot discard lead-time bias in our sample selection. Nevertheless, this bias would not change our main conclusions, because subjects with early seropositivity could have enriched this cohort with respect to susceptibility factors, increasing the differences between the infected and uninfected cohorts. In fact, the main differences we observed were between the at-risk uninfected subjects and the HIV-1-infected subjects. In addition, the singular linkagedisequilibrium pattern observed in the at-risk uninfected cohort highlights their differences with all of the other cohorts.
We have found an overrepresentation of rs4516035-[AAϩAG], rs1544410-[GGϩGA], and rs17878969- [LLϩLS] genotypes in an at-risk uninfected cohort, indicating a dominant effect on protection against HIV-1 infection for the rs4516035-A, rs1544410-G, and rs17878969-L alleles. In addition, when we explored for a VDR multimarker effect on susceptibility to HIV-1, we found a higher prevalence of the 5-marker haplotype G-A-T-G-L in the at-risk uninfected subjects than in both the HIV-1-infected subjects and the healthy subjects. These differences reached statistical significance, being stronger when at-risk uninfected and HIV-1-infected subejcts were compared. We found that the protective haplotype G-A-T-G-L harbors dominant-effect alleles of the aforementioned protective genotypes. Finally, we also detected block-specific haplotypes associated with protection, which were included in the associated 5-marker haplotype. Accordingly, we can consider that the G-A-T-G-L haplotype contains the main contribution to the protection against HIV-1 infection. We also noted that the protective alleles and haplotypes reached their strongest association under a dominant model, indicating that a single copy of the corresponding allele/haplotype is sufficient to confer protection aganist HIV-1 infection.
Haplotypes containing the 3' UTR rs1544410-G allele have been associated with lower mRNA production and stability, which could hamper vitamin D 3 signaling [10] . It has been also described that the exon 2 polymorphism rs10735810-T allele produces a low transactivation capacity of the VDR protein, which could prevent normal VDR function. Finally, several reports have indicated that the VDR promoter polymorphism rs4516035 could be biologically relevant to the immune system [10] .
We propose that the protective haplotype G-A-T-G-L confers lower efficiency to the vitamin D 3 pathway, which also suggests that hampering vitamin D 3 signaling confers protection against HIV-1 transmission. A detrimental effect of the vitamin D 3 -VDR pathway on HIV-1 infection could be explained by (1) vitamin D 3 -mediated up-regulation of HIV-1 receptor expression, (2) down-regulation of antiviral chemokines, and (3) an unbalanced Th2 response. Nevertheless, a direct effect on HIV-1 replication cannot be discarded. In vitro experiments have recently revealed that VDR activates the HIV-1 long terminal repeat in vitro in a ligand-dependent manner [14] .
The association between VDR variants and HIV-1 infection was maintained in the HCV-infected subjects. We did not find a significant association between VDR variants and HCV infection, suggesting that the vitamin D 3 pathway disturbances caused by VDR polymorphisms mainly affect the risk of HIV-1 acquisition. In summary, VDR haplotypes can be considered relevant host modifier factors for HIV-1 transmission in the IDU risk group. Nevertheless, this conclusion should be made with caution, because the results come from the analysis of a limited sample of subjects and require future replication in other risk groups. A complex equation including environmental, genetic, and behavioral factors should be proposed to understand the impact of vitamin D 3 on HIV-1 infection. Our results offer a new scenario to understand the relationship between HIV-1 infection and vitamin D 3 metabolism, including dietary supply and synthesis through sunlight exposure [3, 15] . a Forty-seven at-risk HIV-1-uninfected subjects were recruited from among injection drug users who had participated in a drug-rehabilitation program performed between 1997 and 1999 in Lleida, northeast Spain; seventy-eight at-risk HIV-1-uninfected subjects were selected from among injection drug users who had volunteered to participate in a previous study of the epidemiology of Leishmania infection conducted from April 1998 to July 1999 in Seville, southern Spain. dilution) at a temperature range of 100°C-65°C.
Melting curves were followed in a iCycler system (BioRad).
NOTE. RFLP, restriction fragment-length polymorphism; SSCP, single-strand conformation polymorphism.
a Single-nucleotide polymorphisms (SNPs) were coded by rs no. according to NCBI dbSNP build 1. ) and alleles (2 ϫ 3 tables) showed no significant differences. c Single-marker regression analysis was performed by use of WHAP software. We tested the genotype-dominant model for major alleles by comparing individuals homozygous plus individuals heterozygous for the major allele with individuals homozygous for the minor allele. Markers showing a trend for an association with genotype are indicated in italics.
d Equivalent results were obtained when HIV-1-infected and HIV-1-uninfected (healthy and at-risk subjects considered together) groups were compared. No differences were observed for the comparison of healthy subjects with either HIV-1-infected or at-risk uninfected subjects.
e Eleven at-risk HIV-1-uninfected subjects and 3 HIV-1-infected subjects were missing genotypes for rs11568820 (Cdx) polymorphisms. f rs17878969 (PolyA) allele frequency showed a bimodal distribution with short (S) adenine repeats (13) (14) (15) (16) (17) and long (L) adenine repeats (18 -24) [4] . g An OR could not be estimated by use of WHAP because ⌬32 homozygotes were not observed in the HIV-1-infected cohort. Table 5 . Genotype and allele distribution of VDR markers among healthy control subjects and hepatitis C virus (HCV)-positive subjects (HIV-1 infected and at-risk HIV-1 uninfected) . Table 6 . Haplotype distribution among healthy control subjects and hepatitis C virus (HCV)-positive subjects (HIV infected and at-risk HIV-1 uninfected).
